Kala Bio (KALA) Cash from Financing Activities (2016 - 2026)

Kala Bio has reported Cash from Financing Activities for 11 years, with the latest figure at $4.1 million in Q1 2026.

• Quarterly Cash from Financing Activities rose 3138.52% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.4 million (down 134.65% YoY) and the FY2025 annual result came in at -$11.6 million, down 138.89% from the prior year.
• Cash from Financing Activities advanced to $4.1 million in Q1 2026 per KALA's latest filing, from -$9.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $31.8 million in Q4 2022 and troughed at -$39.9 million in Q3 2022.
• A 5-year average of $1.3 million and a median of $154000.0 in 2022 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities slumped 3341.63% in 2022, then soared 30830.0% in 2023.
• Over 5 years, Cash from Financing Activities stood at $31.8 million in 2022, then tumbled by 92.02% to $2.5 million in 2023, then jumped by 162.17% to $6.6 million in 2024, then slumped by 235.16% to -$9.0 million in 2025, then soared by 145.66% to $4.1 million in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $4.1 million, -$9.0 million, and $30000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.